Add to ORKGType 1 Diabetes is characterized by the destruction of the beta cells. The consequent insulin deficiency leads to chronic hyperglycaemic events, requiring a strict glycaemic control. Several subcutaneous insulin therapies are available, but in some patients with T1D, only CIPII therapy manages to avoid excessive glycemic excursions. The aim of this thesis is to develop a mathematical model to describe the IP insulin absorption in patients with T1D, treated by CIPII therapy
The incidence of Type 1 diabetes is growing yearly. Worryingly, the aetiology of the disease is inco...
For management of type 1 diabetes mellitus (T1DM) to be completely successful, there has to be an ef...
A chronic disease in which human body loses its ability to produce or use the produced insulin known...
Standard insulin therapy to treat type 1 diabetes (T1D) consists of exogenous insulin administration...
Standard insulin therapy to treat type 1 diabetes (T1D) consists of exogenous insulin administration...
Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump is a last-resort treatm...
International audienceSeveral models have been developed for decades. These models have an inherent ...
Continuous intraperitoneal insulin infusion (CIPII) is a treatment option for patients with type 1 d...
Medical scientists have various ways of handling cases of insulin-dependent diabetes diseases of whi...
Abstract. Type 1 diabetics must inject exogenous insulin or insulin analogues one or more times dail...
Continuous intraperitoneal insulin infusion (CIPII) is a treatment option for patients with type 1 d...
Diabetes is a group of metabolic diseases characterized by hyperglycaemia resulting from defects in ...
International audienceA new glucose-insulin model is introduced which fits with the clinical data fr...
[EN] Diabetes mellitus type 1 is a condition in which the pancreas loses its ability to produce enou...
OBJECTIVE - Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump has been av...
The incidence of Type 1 diabetes is growing yearly. Worryingly, the aetiology of the disease is inco...
For management of type 1 diabetes mellitus (T1DM) to be completely successful, there has to be an ef...
A chronic disease in which human body loses its ability to produce or use the produced insulin known...
Standard insulin therapy to treat type 1 diabetes (T1D) consists of exogenous insulin administration...
Standard insulin therapy to treat type 1 diabetes (T1D) consists of exogenous insulin administration...
Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump is a last-resort treatm...
International audienceSeveral models have been developed for decades. These models have an inherent ...
Continuous intraperitoneal insulin infusion (CIPII) is a treatment option for patients with type 1 d...
Medical scientists have various ways of handling cases of insulin-dependent diabetes diseases of whi...
Abstract. Type 1 diabetics must inject exogenous insulin or insulin analogues one or more times dail...
Continuous intraperitoneal insulin infusion (CIPII) is a treatment option for patients with type 1 d...
Diabetes is a group of metabolic diseases characterized by hyperglycaemia resulting from defects in ...
International audienceA new glucose-insulin model is introduced which fits with the clinical data fr...
[EN] Diabetes mellitus type 1 is a condition in which the pancreas loses its ability to produce enou...
OBJECTIVE - Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump has been av...
The incidence of Type 1 diabetes is growing yearly. Worryingly, the aetiology of the disease is inco...
For management of type 1 diabetes mellitus (T1DM) to be completely successful, there has to be an ef...
A chronic disease in which human body loses its ability to produce or use the produced insulin known...